Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135007) titled 'The clinical value of DPP-4 inhibitor Cofrogliptin(Bei Changping) in patients with prediabetes' on Oct. 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Prediabetes
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-11-01
Target Sample Size: intervention group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=333850
Disclaimer: Curated by HT Syndication....